Greiner Bio-One Displays Range of Safety Products at MedLab
|
By LabMedica International staff writers Posted on 31 Jan 2019 |

Image: The VACUETTE range of safety products (Photo courtesy of Greiner Bio-One).
Greiner Bio-One (Kremsmünster, Austria) exhibited its wide range of VACUETTE safety products at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. MedLab is the flagship exhibition and congress of the MedLab Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. The Medlab Series covers all disciplines in the laboratory department and provides a unique platform for the industry’s multi-level professionals to meet under one roof.
Needlestick injuries from contaminated puncture devices are the most common source of infection for diseases transmitted by blood or other bodily fluids and are still among the most common occupational accidents today. Greiner Bio-One Preanalytics has been developing a range of safety products to reduce the risk of contamination and needlestick injuries, providing protection against potential injury risks.
At MedLab Middle East 2019, Greiner Bio-One exhibited its VACUETTE safety blood collection sets, which are particularly suitable for blood collection from patients with difficult veins. An integrated safety mechanism that is already activated in the patient's vein provides even greater safety in the blood collection process. The VACUETTE safety blood collection sets are available in different needle sizes and tubing lengths.
Greiner Bio-One also displayed its VACUETTE QUICKSHIELD safety tube holder, which enables greater flexibility related to user and patient-specific requirements due to its rotating safety shield. Additionally, the holder’s ergonomic design provides the user with a better grip for puncturing. The safety shield can be activated either one-handed with the aid of a solid surface or simply with the thumb.
Needlestick injuries from contaminated puncture devices are the most common source of infection for diseases transmitted by blood or other bodily fluids and are still among the most common occupational accidents today. Greiner Bio-One Preanalytics has been developing a range of safety products to reduce the risk of contamination and needlestick injuries, providing protection against potential injury risks.
At MedLab Middle East 2019, Greiner Bio-One exhibited its VACUETTE safety blood collection sets, which are particularly suitable for blood collection from patients with difficult veins. An integrated safety mechanism that is already activated in the patient's vein provides even greater safety in the blood collection process. The VACUETTE safety blood collection sets are available in different needle sizes and tubing lengths.
Greiner Bio-One also displayed its VACUETTE QUICKSHIELD safety tube holder, which enables greater flexibility related to user and patient-specific requirements due to its rotating safety shield. Additionally, the holder’s ergonomic design provides the user with a better grip for puncturing. The safety shield can be activated either one-handed with the aid of a solid surface or simply with the thumb.
Latest MEDLAB 2019 News
- ERBA Group Launches New Hematology Analyzers at MEDLAB 2019
- Telstar Promotes Latest Generation of Freeze Dryers in Dubai
- Siemens Healthineers Showcases In-Vitro Diagnostics Products at MedLab 2019
- Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer
- Mindray Displays New Generation Benchtop Cellular Analysis Line
- HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show
- EKF Diagnostics Presents Latest Diabetes Care Analyzers
- BioSystems Highlights New iFOB Integral System at MedLab 2019
- Beckman Coulter Exhibits New Hematology Analyzer in Middle East
- Agappe Diagnostics Displays Analyzers and Solutions at Middle East Congress
- Abbott Highlights Point of Care Management Solutions
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read more
Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer
Adjuvant therapy decisions after curative surgery for colon cancer remain difficult, as conventional clinicopathologic factors often fail to capture residual disease risk. Liquid biopsy approaches that... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
Gut Microbiome Signatures Help Identify Risk of IBD Progression
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more
FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel









